Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: tktrimbath who wrote (449)	10/12/2005 1:10:38 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 557

Maybe I have just become overly cynical. But my guess is that if there is a technology worth a damn, after sitting out there for maybe a few years, it is eventually going to get bought out by big pharma. I think Tgen ought to have been bought out by now--who knows, maybe Amgen will gobble them up. I think the chance for a ten or hundred bagger is next to none. Seems like Parker is getting up around the age where you might expect her to retire--or move on to something different. (he says, not knowing for sure if she is still the CEO!) But you're right--no harm in holding the shares if they're not worth much anyway. I held some Global Crossing right to zero, hardly seemed worth giving them up. Lost less than ten grand on it, which at the time seemed like peanuts. However, I'd have done better to spend that money on a big poker tourney, or, come to think of it, a charity. Oh well, live and learn. I probably should have held my tongue on this--I have advice that is just barely good enough for my five year old and that is about it these days. But I type faster than I think, so that is great fun anyway <g>.

To: tktrimbath who wrote (449)	10/14/2005 12:57:19 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 557

Saw a blurb in Businessweek about Ceregene (Cell Genesys spinoff, has not gone public, delivery of neurotrophic factors with AAV). You may want to review that company--I seem to remember that Parker in her speeches emphasized that Tgen had a edge in producing AAV. I could imagine some sort of a deal where Tgen and Ceregene merge--I think the jargon is 'reverse IPO' etc etc. Not sure that would give you much for your tgen shares in the short term, but for all I know Ceregene's Parkinson therapy is genuine blockbuster material. Here is their PR page: ceregene.com Oh for crying out loud--there is that John Walker guy again. Unbelievable, they must all golf together.